ISPC vs MKTX · rev $9.3M vs P/E 13, rev $817.1M
iSpecimen Inc (ISPC) versus MarketAxess Holdings Inc (MKTX) — a side-by-side from cached financials, not a winner call.
iSpecimen Inc (ISPC) is a diagnostics & research company listed on US.
MarketAxess Holdings Inc (MKTX) is a capital markets company listed on US.
Latest reported ISPC revenue for 2024-12-31 was $9.3M. Net income was -$12.5M. Revenue was down 6.4% from 2023-12-31 to 2024-12-31. ISPC currently screens at market cap $4.4M.
Latest reported MKTX revenue for 2024-12-31 was $817.1M. Net income was $274.2M. Revenue was up 8.6% from 2023-12-31 to 2024-12-31. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
ISPC currently screens at market cap $4.4M. MKTX currently screens at market cap $4.00B and trailing P/E 13.3.
Not investment advice. Open the ISPC and MKTX stock pages for the full models.
Not investment advice.